Point72 Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Buy |
507,790
+188,887
| +59% | +$5.95M | 0.03% | 478 |
|
|
2025
Q1 | $10.4M | Buy |
318,903
+292,075
| +1,089% | +$9.57M | 0.02% | 526 |
|
|
2024
Q4 | $970K | Buy |
+26,828
| New | +$970K | ﹤0.01% | 886 |
|
|
2024
Q3 | – | Sell |
-136,342
| Closed | -$3.65M | – | 1667 |
|
|
2024
Q2 | $3.65M | Buy |
136,342
+8,521
| +7% | +$228K | 0.01% | 681 |
|
|
2024
Q1 | $4.36M | Buy |
+127,821
| New | +$4.36M | 0.01% | 744 |
|
|
2023
Q2 | – | Sell |
-755
| Closed | -$27.4K | – | 2140 |
|
|
2023
Q1 | $27.4K | Buy |
+755
| New | +$27.4K | ﹤0.01% | 1397 |
|
|
2020
Q2 | – | Sell |
-346,666
| Closed | -$6.24M | – | 974 |
|
|
2020
Q1 | $6.24M | Buy |
+346,666
| New | +$6.24M | 0.05% | 340 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1050 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1036 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 993 |
|
|
2017
Q1 | – | Sell |
-1,900
| Closed | -$48K | – | 847 |
|
|
2016
Q4 | $48K | Buy |
+1,900
| New | +$48K | ﹤0.01% | 618 |
|
|
2016
Q3 | – | Sell |
-35,600
| Closed | -$725K | – | 782 |
|
|
2016
Q2 | $725K | Sell |
35,600
-909,146
| -96% | -$18.5M | ﹤0.01% | 580 |
|
|
2016
Q1 | $14.4M | Buy |
+944,746
| New | +$14.4M | 0.11% | 207 |
|